These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 33788858)

  • 1. Impact of the COVID-19 pandemic on skin cancer diagnosis: A population-based study.
    Asai Y; Nguyen P; Hanna TP
    PLoS One; 2021; 16(3):e0248492. PubMed ID: 33788858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic Delays for Non-melanoma Skin Cancers in Renal Transplant Recipients during the COVID-19 Pandemic: What is Hiding Behind the Mask?
    Mokos M; Bašić-Jukić N
    Acta Dermatovenerol Croat; 2021 Jul; 29(2):111-113. PubMed ID: 34477079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of the COVID-19 pandemic on keratinocyte carcinoma in the Netherlands: Trends in diagnoses and magnitude of diagnostic delays.
    Slotman E; Schreuder K; Nijsten TEC; Wakkee M; Hollestein L; Mooyaart A; Siesling S; Louwman MWJ
    J Eur Acad Dermatol Venereol; 2022 May; 36(5):680-687. PubMed ID: 35092107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of the COVID-19 pandemic on the diagnosis of cutaneous melanomas: A retrospective cohort study from five European skin cancer reference centres.
    Troesch A; Hoellwerth M; Forchhammer S; Del Regno L; Lodde G; Turko P; Cheng PF; Levesque ML; Hadaschik E; Livingstone E; Peris K; Flatz L; Koelblinger P; Dummer R; Dimitriou F
    J Eur Acad Dermatol Venereol; 2023 May; 37(5):922-931. PubMed ID: 36785973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Impact of and Adaptations Due to the COVID-19 Pandemic on the Histopathological Diagnosis of Skin Pathologies, Including Non-Melanocyte and Melanoma Skin Cancers-A Single-Center Study in Romania.
    Cocuz IG; Cocuz ME; Niculescu R; Șincu MC; Tinca AC; Sabău AH; Chiorean DM; Morariu SH; Cotoi OS
    Medicina (Kaunas); 2021 May; 57(6):. PubMed ID: 34071770
    [No Abstract]   [Full Text] [Related]  

  • 6. Limited impact of COVID-19-related diagnostic delay on cutaneous melanoma and squamous cell carcinoma tumour characteristics: a nationwide pathology registry analysis.
    Sangers TE; Wakkee M; Kramer-Noels EC; Nijsten T; Louwman MWJ; Jaspars EH; Hollestein LM
    Br J Dermatol; 2022 Aug; 187(2):196-202. PubMed ID: 35141890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delivery of Cancer Care in Ontario, Canada, During the First Year of the COVID-19 Pandemic.
    Walker MJ; Wang J; Mazuryk J; Skinner SM; Meggetto O; Ashu E; Habbous S; Nazeri Rad N; Espino-Hernández G; Wood R; Chaudhry M; Vahid S; Gao J; Gallo-Hershberg D; Gutierrez E; Zanchetta C; Langer D; Zwicker V; Rey M; Tammemägi MC; Tinmouth J; Kupets R; Chiarelli AM; Singh S; Warde P; Forbes L; Dobranowski J; Irish J; Rabeneck L;
    JAMA Netw Open; 2022 Apr; 5(4):e228855. PubMed ID: 35467731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Approach to skin malignancies in COVID-19 pandemic days.
    Aslan Kayıran M; Karadag AS; Wollina U
    J Biol Regul Homeost Agents; 2020; 34(6):1977-1982. PubMed ID: 33111514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer Diagnostic Delay in Northern and Central Italy During the 2020 Lockdown Due to the Coronavirus Disease 2019 Pandemic.
    Ferrara G; De Vincentiis L; Ambrosini-Spaltro A; Barbareschi M; Bertolini V; Contato E; Crivelli F; Feyles E; Mariani MP; Morelli L; Orvieto E; Pacella E; Venturino E; Saragoni L
    Am J Clin Pathol; 2021 Jan; 155(1):64-68. PubMed ID: 32995855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New Cancer Diagnoses Before and During the COVID-19 Pandemic.
    Decker KM; Feely A; Bucher O; Czaykowski P; Hebbard P; Kim JO; Pitz M; Singh H; Thiessen M; Lambert P
    JAMA Netw Open; 2023 Sep; 6(9):e2332363. PubMed ID: 37669049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decrease in gynecological cancer diagnoses during the COVID-19 pandemic: an Austrian perspective.
    Tsibulak I; Reiser E; Bogner G; Petru E; Hell-Teutsch J; Reinthaller A; Weirather C; Weiss T; Bozsa S; Puschacher B; Hall M; Hittler D; Hrauda K; Thell E; Clauss S; Pozniak J; Alicke S; Gangl D; Gamperl G; Ebner C; Knoll K; Leitner K; Schilcher A; Schinnerl M; Sigl V; Singer C; Aigmüller T; Hofstätter B; Marth C
    Int J Gynecol Cancer; 2020 Nov; 30(11):1667-1671. PubMed ID: 33033166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary Care-Based Skin Cancer Screening in a Veterans Affairs Health Care System.
    Swetter SM; Chang J; Shaub AR; Weinstock MA; Lewis ET; Asch SM
    JAMA Dermatol; 2017 Aug; 153(8):797-801. PubMed ID: 28593242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The magnitude of COVID-19's effect on the timely management of melanoma and nonmelanoma skin cancers.
    Marson JW; Maner BS; Harding TP; Meisenheimer J; Solomon JA; Leavitt M; Levin NJ; Dellavalle R; Brooks I; Rigel DS
    J Am Acad Dermatol; 2021 Apr; 84(4):1100-1103. PubMed ID: 33482258
    [No Abstract]   [Full Text] [Related]  

  • 15. Decline and incomplete recovery in cancer diagnoses during the COVID-19 pandemic in Belgium: a year-long, population-level analysis.
    Peacock HM; Tambuyzer T; Verdoodt F; Calay F; Poirel HA; De Schutter H; Francart J; Van Damme N; Van Eycken L
    ESMO Open; 2021 Aug; 6(4):100197. PubMed ID: 34474811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer diagnostic rates during the 2020 'lockdown', due to COVID-19 pandemic, compared with the 2018-2019: an audit study from cellular pathology.
    De Vincentiis L; Carr RA; Mariani MP; Ferrara G
    J Clin Pathol; 2021 Mar; 74(3):187-189. PubMed ID: 32561524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shifts in office and virtual primary care during the early COVID-19 pandemic in Ontario, Canada.
    Glazier RH; Green ME; Wu FC; Frymire E; Kopp A; Kiran T
    CMAJ; 2021 Feb; 193(6):E200-E210. PubMed ID: 33558406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of the COVID-19 pandemic on diagnosis of new cancers: A national multicenter study of the Veterans Affairs Healthcare System.
    Englum BR; Prasad NK; Lake RE; Mayorga-Carlin M; Turner DJ; Siddiqui T; Sorkin JD; Lal BK
    Cancer; 2022 Mar; 128(5):1048-1056. PubMed ID: 34866184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The initial impact of the COVID-19 pandemic on the diagnosis of new cancers at a large pathology laboratory in the public health sector, Western Cape Province, South Africa.
    Van Wyk AC; De Jager LJ; Razack R; Van Wyk SS; Kleinhans W; Simonds HM; Schubert PT
    S Afr Med J; 2021 May; 111(6):570-574. PubMed ID: 34382569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of the COVID-19 pandemic in 2020 on the diagnosis, treatment, and outcomes of invasive cutaneous melanoma: A retrospective national cohort study.
    Xiong DD; Bordeaux J
    J Am Acad Dermatol; 2023 Dec; 89(6):1167-1176. PubMed ID: 37625699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.